Pharmaceutical News and Articles

At-Home Urine Test Can Detect Aggressive Prostate Cancer

It s tough for a man to know what to do following a diagnosis of prostate cancer. The treatment is often worse than the risk posed by the cancer itself, causing

Heart Health At Risk For New Moms Of Twins

New moms who ve just had twins run a high risk of heart disease in the coming weeks and months, a new study suggests. Women have a doubled risk of hospitalizati

Many Americans Misguided On Daily Aspirin, Survey Finds

Many Americans don t see anything wrong with taking daily low-dose aspirin, even though experts have concluded its risks outweigh its benefits, a new survey has

Firearms Injuries Shot Up Following Pandemic, Study Says

Hospitalizations for firearm injuries sharply increased in the wake of the COVID-19 pandemic after years of steady decline, a new study says. Overall, 34 more p

Scholar Rock Submits Biologics License Application (BLA) to the U.S. FDA for Apitegromab as a Treatment for Patients with Spinal Muscular Atrophy (SMA)

Beta Blocker Propranolol Might Reduce Migraine Stroke Risk

protecting women against stroke. Women taking the beta blocker propranolol to ward off migraines have a lower risk of strokes caused by blood clots, according t

Key CDC Health Websites Vanish Following Trump Orders

The U.S. Centers for Disease Control and Prevention (CDC) has taken down multiple health-related websites and datasets, including those on HIV, LGBTQ health and

No Evidence Found Linking Sickle Cell Trait With Unexplained Sudden Death

There is no evidence to support physical exertion without rhabdomyolysis or heat injury causing sudden death in individuals with sickle cell trait (SCT), nor is

Metabolic Surgery May Be Beneficial in MASH-Related Cirrhosis, Obesity

For patients with compensated metabolic dysfunction-associated steatohepatitis (MASH)-related cirrhosis and obesity, metabolic surgery is associated with a lowe

FDA Approval Expands Earlier Use of Enhertu for Metastatic Breast Cancer

The U.S. Food and Drug Administration has approved Enhertu (trastuzumab deruxtecan) for the treatment of adult patients with unresectable or metastatic hormone